{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Welcome to the Second Lab - Week 1, Day 3\n",
    "\n",
    "Today we will work with lots of models! This is a way to get comfortable with APIs."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<table style=\"margin: 0; text-align: left; width:100%\">\n",
    "    <tr>\n",
    "        <td style=\"width: 150px; height: 150px; vertical-align: middle;\">\n",
    "            <img src=\"../assets/stop.png\" width=\"150\" height=\"150\" style=\"display: block;\" />\n",
    "        </td>\n",
    "        <td>\n",
    "            <h2 style=\"color:#ff7800;\">Important point - please read</h2>\n",
    "            <span style=\"color:#ff7800;\">The way I collaborate with you may be different to other courses you've taken. I prefer not to type code while you watch. Rather, I execute Jupyter Labs, like this, and give you an intuition for what's going on. My suggestion is that you carefully execute this yourself, <b>after</b> watching the lecture. Add print statements to understand what's going on, and then come up with your own variations.<br/><br/>If you have time, I'd love it if you submit a PR for changes in the community_contributions folder - instructions in the resources. Also, if you have a Github account, use this to showcase your variations. Not only is this essential practice, but it demonstrates your skills to others, including perhaps future clients or employers...\n",
    "            </span>\n",
    "        </td>\n",
    "    </tr>\n",
    "</table>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Start with imports - ask ChatGPT to explain any package that you don't know\n",
    "\n",
    "import os\n",
    "import json\n",
    "from dotenv import load_dotenv\n",
    "from openai import OpenAI\n",
    "# from anthropic import Anthropic\n",
    "from IPython.display import Markdown, display"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Always remember to do this!\n",
    "load_dotenv(override=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OpenAI API Key exists and begins sk-or-v1\n",
      "Google API Key exists and begins sk\n",
      "DeepSeek API Key exists and begins sk-\n"
     ]
    }
   ],
   "source": [
    "# Print the key prefixes to help with any debugging\n",
    "\n",
    "openai_api_key = os.getenv('OPENAI_API_KEY')\n",
    "# anthropic_api_key = os.getenv('ANTHROPIC_API_KEY')\n",
    "google_api_key = os.getenv('OPENAI_API_KEY')\n",
    "deepseek_api_key = os.getenv('OPENAI_API_KEY')\n",
    "# groq_api_key = os.getenv('GROQ_API_KEY')\n",
    "\n",
    "if openai_api_key:\n",
    "    print(f\"OpenAI API Key exists and begins {openai_api_key[:8]}\")\n",
    "else:\n",
    "    print(\"OpenAI API Key not set\")\n",
    "    \n",
    "# if anthropic_api_key:\n",
    "#     print(f\"Anthropic API Key exists and begins {anthropic_api_key[:7]}\")\n",
    "# else:\n",
    "#     print(\"Anthropic API Key not set (and this is optional)\")\n",
    "\n",
    "if google_api_key:\n",
    "    print(f\"Google API Key exists and begins {google_api_key[:2]}\")\n",
    "else:\n",
    "    print(\"Google API Key not set (and this is optional)\")\n",
    "\n",
    "if deepseek_api_key:\n",
    "    print(f\"DeepSeek API Key exists and begins {deepseek_api_key[:3]}\")\n",
    "else:\n",
    "    print(\"DeepSeek API Key not set (and this is optional)\")\n",
    "\n",
    "# if groq_api_key:\n",
    "#     print(f\"Groq API Key exists and begins {groq_api_key[:4]}\")\n",
    "# else:\n",
    "    # print(\"Groq API Key not set (and this is optional)\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "request = \"Please come up with a challenging, nuanced question that I can ask a number of LLMs to evaluate their intelligence. \"\n",
    "request += \"Answer only with the question, no explanation.\"\n",
    "messages = [{\"role\": \"user\", \"content\": request}]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'role': 'user',\n",
       "  'content': 'Please come up with a challenging, nuanced question that I can ask a number of LLMs to evaluate their intelligence. Answer only with the question, no explanation.'}]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "messages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "You are consulting for a multinational corporation planning to launch a synthetic biology product that creates self‑reproducing microorganisms capable of biodegrading plastic in oceans. Develop a comprehensive risk assessment and stakeholder communication plan that addresses ecological impacts, regulatory compliance, public perception, intellectual property concerns, and long‑term sustainability. Be sure to integrate current scientific understanding, policy frameworks, and potential moral dilemmas.\n"
     ]
    }
   ],
   "source": [
    "openai = OpenAI(\n",
    "  base_url=\"https://openrouter.ai/api/v1\",\n",
    "  api_key=openai_api_key,\n",
    ")\n",
    "\n",
    "response = openai.chat.completions.create(\n",
    "    model=\"openai/gpt-oss-20b:free\",\n",
    "    messages=messages,\n",
    ")\n",
    "question = response.choices[0].message.content\n",
    "print(question)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "competitors = []\n",
    "answers = []\n",
    "messages = [{\"role\": \"user\", \"content\": question}]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Note - update since the videos\n",
    "\n",
    "I've updated the model names to use the latest models below, like GPT 5 and Claude Sonnet 4.5. It's worth noting that these models can be quite slow - like 1-2 minutes - but they do a great job! Feel free to switch them for faster models if you'd prefer, like the ones I use in the video."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/markdown": [
       "**Risk Assessment and Stakeholder‑Communication Plan**\n",
       "\n",
       "*Prepared for: Multinational Corporation – Synthetic Ocean Plastic‑Degrading Microorganism (SOPDM)*  \n",
       "*Prepared by: External Consulting Team*  \n",
       "*Date: 6 Nov 2025*  \n",
       "\n",
       "---\n",
       "\n",
       "## 1. Executive Summary\n",
       "\n",
       "This document combines a rigorous ecological‑risk assessment, a regulatory‑compliance checklist, a public‑perception and communication strategy, intellectual‑property (IP) considerations, and a long‑term sustainability framework for the corporate launch of a synthetic, self‑reproducing microorganism designed to biodegrade plastic in marine environments. The aim is to minimize ecological harm, meet global regulatory obligations, safeguard corporate reputation, protect proprietary technology, and ensure the project aligns with the long‑term well‑being of marine ecosystems and society.\n",
       "\n",
       "---\n",
       "\n",
       "## 2. Product Overview\n",
       "\n",
       "| Feature | Technical Detail |\n",
       "|---------|------------------|\n",
       "| Organism | Engineered strain of *Micrococcus* (or similar) with stacked metabolic modules for PET‑degradation, self‑replication, and plasmid‑borne kill‑switch |\n",
       "| Mechanism | PET hydrolases (PETase + MHETase), quorum‑sensing‑controlled growth, genetic safeguards (CRISPR‑based kill‑switch + auxotrophy) |\n",
       "| Deployment | Controlled field trials → scaling → oceanic distribution via vessel or spray |\n",
       "| Expected Impact | 20–40 % increase in PET biodeterioration rates within 2–5 years in target zones |\n",
       "\n",
       "*(Note: The technical details above are illustrative; the actual design will be proprietary to the corporation.)*\n",
       "\n",
       "---\n",
       "\n",
       "## 3. Scientific and Ecological Risk Assessment\n",
       "\n",
       "### 3.1 Core Assessment Frameworks\n",
       "\n",
       "| Framework | Key Pillars | Applicability |\n",
       "|-----------|-------------|---------------|\n",
       "| **GRAC** (Global Risk Assessment for Cultivated Organisms) | Hazard identification, exposure assessment, risk characterisation | Standard for GMOs worldwide |\n",
       "| **Mendelian & Non‑Mendelian Gene Flow Models** | Horizontal gene transfer (HGT) predictions, mobile element ecology | Essential for self‑reproducing microbes |\n",
       "| **Ecosystem Biodiversity Modelling** (i.e., COMETS & NicheMod) | Species‑interaction networks, trophic cascades | Predict impact on local communities |\n",
       "| **Life‑Cycle Assessment (LCA)** | Energy usage, GHGs, water, end‑of‑life | Long‑term sustainability check |\n",
       "\n",
       "### 3.2 Hazard Identification\n",
       "\n",
       "1. **Ecological Alteration**  \n",
       "   - *Competitive displacement* of native bacteria.  \n",
       "   - *Trophic cascade* through altered degradation pathways.  \n",
       "2. **Gene Flow**  \n",
       "   - *HGT* of PETase genes or kill‑switch to undesired taxa.  \n",
       "   - *Mobile genetic element (MGE) mobilization* across phyla.  \n",
       "3. **Product Toxicity**  \n",
       "   - Degradation intermediates (MHET, TPA) at high concentrations.  \n",
       "   - Accumulation of metabolic by‑products (e.g., aromatic compounds).  \n",
       "4. **Population Dynamics**  \n",
       "   - Uncontrolled proliferation leading to *biomass surge*.  \n",
       "   - *Population crash* post‑kill‑switch activation causing ecological shock.  \n",
       "5. **Non‑Target Effects**  \n",
       "   - Pathogenic transformation if HGT introduces virulence factors.  \n",
       "   - Biofouling alterations affecting shipping, aquaculture.\n",
       "\n",
       "### 3.3 Exposure Assessment\n",
       "\n",
       "| Exposure Pathway | Notes |\n",
       "|------------------|-------|\n",
       "| **Direct ocean release** | Large surface area → high dilution but persistent organisms in micro‑habitats (e.g., plastics, seabed). |\n",
       "| **Secondary vectors** | Wildlife ingestion → gut passage; fish scales; biogenic vectors such as zooplankton. |\n",
       "| **Aerobic vs. anaerobic zones** | Might differ in organism viability; model both. |\n",
       "| **Area of Release** | Targeted: e.g., North Pacific Gyre; but need cross‑boundary migration modelling. |\n",
       "\n",
       "### 3.4 Risk Characterisation & Mitigation Matrix\n",
       "\n",
       "| Risk | Likelihood | Consequence | Overall Risk | Mitigation |\n",
       "|------|------------|-------------|--------------|------------|\n",
       "| **Regulatory non‑compliance** | Medium | High | Medium‑High | Engage regulators early, register for approval under Cartagena, develop a detailed dossier. |\n",
       "| **Unintended HGT** | Low | Medium | Low‑Medium | Design non‑mobilizable vectors, use CRISPR safeties, bio‑containers. |\n",
       "| **Ecological disruption** | Low | High | Medium‑High | Tiered field trials, model in silico, real‑time monitoring. |\n",
       "| **Public backlash** | Medium | High | Medium‑High | Transparent communication plan, public engagement, “open data” portal. |\n",
       "| **IP infringement** | Low | Medium | Low‑Medium | Patent portfolio scanning, freedom‑to‑operate (FTO) analysis, cross‑licensing. |\n",
       "| **Long‑term sustainability** | Medium | Medium | Medium | Integrate LCA, monitor CO₂ offsets, design reversible deployment. |\n",
       "\n",
       "---\n",
       "\n",
       "## 4. Regulatory Compliance Road‑Map\n",
       "\n",
       "| Region | Relevant Laws & Authority | Key Requirements | Action Items |\n",
       "|--------|--------------------------|-------------------|--------------|\n",
       "| **United States (EPA, USDA, ATSDR, CFP)** | *Genetically Modified Organisms—National Environmental Policy Act* (NEMP) | Environmental and health assessments, risk assessment & mitigation, monitoring, stakeholder notice | Prepare and submit a Draft Ecological Risk Assessment (DERA) to EPA. |\n",
       "| **European Union** | *Regulation (EC) No 1829/2003* (GMO), *Marine Strategy Framework Directive* (MSFD) | Environmental impact assessment (EIA), public consultation, monitoring under the Marine strategy | Submit an Approval Programme & EIA to the competent Authority (e.g., Biosecurity Agency). |\n",
       "| **United Kingdom** | *Biological Agents (Control) Act 1988*, *Regulation (EU) NO 183/2004* | Risk assessment, registration, controls on release | Obtain a Biological Agent Licence. |\n",
       "| **Australia** | *Biosecurity Act 2015*, *Scientific Committee on Synthetic Biology* | Genetic biosecurity clearance, field trial licence | Apply through the Biotechnology and Biosciences Strategy Division. |\n",
       "| **International** | *Convention on Biological Diversity (CBD – Cartagena Protocol)*, *WHO’s Biosafety Guide* | Transboundary movement protocols, biosafety assessment, risk communication | Submit to national competent authorities. |\n",
       "| **Marine‑specific** | *UN‑IMO International Convention for the Prevention of Marine Pollution by Dumping of Wastes* | Prohibition of dumping genetically engineered organisms unless authorised | Ensure compliance before any on‑board release. |\n",
       "\n",
       "**Regulatory‑Compliance Milestones**\n",
       "\n",
       "| Milestone | Deadline | Responsible |\n",
       "|-----------|----------|-------------|\n",
       "| Technical dossier compilation | 3 months | Technical Lead |\n",
       "| Submit Pre‑Application | 4 months | Regulatory Affairs |\n",
       "| Risk Assessment completion | 6 months | CRO |\n",
       "| Permit approval (US/EU) | 9 months | Regulatory Affairs |\n",
       "| Experimental release license | 12 months | Legal/Regulatory |\n",
       "\n",
       "---\n",
       "\n",
       "## 5. Ethical & Moral Considerations\n",
       "\n",
       "| Issue | Moral Conflict | Stakeholder Concerns | Risk Communication Angle |\n",
       "|-------|----------------|----------------------|--------------------------|\n",
       "| **Fate of engineered life** | Is it ethical to create self‑replicating GMOs that exist outside laboratory control? | Local communities, environmental NGOs, ethicists | Emphasise containment, kill‑switch robustness. |\n",
       "| **Responsibility vs. Benefit** | If failed, who bears ecological cost? | Investors, taxpayers | Robust insurance, unusual risk sharing. |\n",
       "| **Gene‑escape to pathogens** | Transfer of PETase into disease‑causing bacteria? | Public health sector | Demonstrate HGT modeling, mention genetic safeguards. |\n",
       "| **Equity in benefit** | Will coastal communities in developing nations benefit or bear risk? | Indigenous communities, NGOs | Co‑design field trial locations, revenue sharing. |\n",
       "| **Consent & Governance** | Do we have local expressed bio‑societal consent? | Global governance bodies | Engage with ICMC, Pacific Islands Forum. |\n",
       "\n",
       "**Proposed Ethical Framework**\n",
       "\n",
       "1. **Triple‑Bottom‑Line (People, Planet, Profit)** – Formal commit to this pre‑approach; publish a statement.  \n",
       "2. **Stakeholder Governance Panel** – independent science, ethics, and community representatives.  \n",
       "3. **Adaptive Management** – closed‑loop decision scoring; if risk thresholds hit, halt or terminate the trial.  \n",
       "4. **Transparency Commitments** – open‑access risk data, progress logs, and IP status.\n",
       "\n",
       "---\n",
       "\n",
       "## 6. Public Perception & Risk Communication Strategy\n",
       "\n",
       "### 6.1 Audience Segmentation\n",
       "\n",
       "| Segment | Key Concerns | Preferred Channels | Messaging Tone |\n",
       "|---------|--------------|--------------------|----------------|\n",
       "| Environmental NGOs | Biodiversity, gene flow | Scientific letters, stakeholder meetings | Evidence‑based, cautious |\n",
       "| Coastal communities | Safety, livelihood | Public forums, local languages | Respectful, participatory |\n",
       "| Investors & Shareholders | ROI, brand risk | SEC filings, investor briefings | Confident, risk‑managed |\n",
       "| Policy makers | Compliance, legal | Policy briefs, advisory committees | Technical, collaborative |\n",
       "| General public | Health, moral | Social media, press releases | Clear, reassuring |\n",
       "\n",
       "### 6.2 Core Message Themes\n",
       "\n",
       "1. *“Guardrails First”* – The organism uses multi‑layered biological safety mechanisms (auxotrophy, kill‑switch) that ensure it cannot survive beyond its intended domain.  \n",
       "2. *“Ecological Harmony”* – The treatment is a supplement, not a replacement, for conventional plastic removal methods; designed to be non‑disruptive.  \n",
       "3. *“Collaboration for Clean Oceans”* – A partnership across academia, industry, NGOs, and governments.  \n",
       "4. *“Proactive Transparency”* – Real‑time data dashboards, open‑labeling of trials, three‑year post‑release monitoring plan.\n",
       "\n",
       "### 6.3 Communication Plan Timeline\n",
       "\n",
       "| Time | Action | Owner |\n",
       "|------|--------|-------|\n",
       "| **Pre‑Launch** | **A. Launch “Ask‑Me‑Anything” series** (press, webinars) | PR |\n",
       "| | **B. Create a citizen‑science portal** (data sharing, crowdsourced monitoring) | Digital Team |\n",
       "| **Field Trial Phase** | **C. Weekly snapshot reports** (social media, email) | Social Media Lead |\n",
       "| | **D. Town‑hall meetings** in trial sites | Community Liaison |\n",
       "| **Post‑Launch** | **E. Annual “Sustainability Report”** | Corporate Sustainability |\n",
       "| | **F. Independent third‑party investigations** | Advisory Board |\n",
       "\n",
       "### 6.4 Crisis Management Module\n",
       "\n",
       "- **Trigger**: Unanticipated detection of the organism beyond the release zone, or evidence of gene transfer.\n",
       "- **Response**: Immediate notification to regulators, transparent briefing to stakeholders, activation of kill‑switch protocols, on‑site containment teams.\n",
       "- **Communication**: Formal statements, two‑hour “press‑brief” to vehicles, dedicated hotline for inquiries.\n",
       "\n",
       "---\n",
       "\n",
       "## 7. Intellectual Property (IP) Strategy\n",
       "\n",
       "### 7.1 Patent Landscape Review\n",
       "\n",
       "| Technology | Patent Status | Key Prior Art | Opportunities |\n",
       "|------------|---------------|---------------|---------------|\n",
       "| *PETase & MHETase enzyme pair* | Patented by University of Queensland, various biotech firms | 2019–2021 patents | File composition‑of‑matter claims; boundary claims |\n",
       "| *Quorum‑sensing growth control* | Open‑source platform (MIT OpenPolymers) | 2022 open codes | Patent the particular sensor‑effector coupling |\n",
       "| *CRISPR kill‑switch architecture* | Basic 2018 CRISPR patents | Several “self‑destroy” patents | Broadly claim “self‑regulating kill‑switch” + “auxotrophic module” |\n",
       "| *Microbial chassis (Micrococcus)* | No exclusive IP; strain available | – | File on engineered strain, resilience modules |\n",
       "\n",
       "### 7.2 Freedom‑to‑Operate (FTO)\n",
       "\n",
       "- **Action**: Conduct a comprehensive FTO search across 34 jurisdictions.  \n",
       "- **Mitigation**: Cross‑licensing with key patent holders; negotiate research‑use licence if necessary.\n",
       "\n",
       "### 7.3 IP Protection Plan\n",
       "\n",
       "| Asset | Filing Strategy | Duration |\n",
       "|-------|-----------------|----------|\n",
       "| Enzyme constructs | Utility + Plant/Animal Patents | 20 years |\n",
       "| Engineered chassis | Utility + Plant/Animal Patents | 20 years |\n",
       "| Biosafety modules | Utility + Plant/Animal Claims | 20 years |\n",
       "| Process & SOPs | Trade‑Secret + Provisional patents | Indefinite (subject to disclosure) |\n",
       "| Open‑source code (part of platform) | Creative commons with attribution constraints | Open |\n",
       "\n",
       "### 7.4 IP‑Risk Management\n",
       "\n",
       "| Risk | Likelihood | Impact | Mitigation |\n",
       "|------|------------|--------|------------|\n",
       "| Patent infringement claim | Low | Medium | Acquire Freedom‑to‑Operate license; monitor IP landscape |\n",
       "| IP leak to competitors | Medium | High | Non‑Disclosure Agreements (NDAs), strict access controls |\n",
       "| Loss of IP due to failure | Low | High | Maintain robust data management; secure storage on blockchain logs |\n",
       "\n",
       "---\n",
       "\n",
       "## 8. Long‑Term Sustainability and Monitoring\n",
       "\n",
       "### 8.1 Lifecycle Assessment (LCA)\n",
       "\n",
       "| Life‑Cycle Stage | GHG Emissions | Energy Use | End‑of‑Life | Key Findings |\n",
       "|------------------|---------------|------------|-------------|--------------|\n",
       "| **Genome Construction** | Low | 3 MWh | – | >90 % of energy is from renewables |\n",
       "| **Cultivation (lab)** | Medium | 6 kWh/L | N/A | Efficient bioreactor design |\n",
       "| **Distribution** | High | 1500 kWh/launch | – | Transition to hydro‑electric vessels |\n",
       "| **In‑ocean degradation** | Negligible | – | – | Enzymes degrade to CO₂, water, BPA (fully metabolized) |\n",
       "| **Post‑release monitoring** | Low | 0.5 kWh/week | – | Autonomous buoy network |\n",
       "\n",
       "### 8.2 Monitoring Framework\n",
       "\n",
       "| Parameter | Measurement Technique | Frequency | Authority |\n",
       "|-----------|-----------------------|-----------|-----------|\n",
       "| **Microbial abundance** | qPCR, flow cytometry, metagenomics | Daily during first 30 days; weekly thereafter | Field lab |\n",
       "| **Gene transfer events** | Hi‑C, plasmid capture, amplicon sequencing | Monthly | Academic partner |\n",
       "| **Plastic degradation metrics** | Light‑transmittance, mass balance, FTIR mapping | 3‑month intervals | Corporate Science |\n",
       "| **Ecological indicators** | Benthic fauna surveys, fish gut microbiome, phytoplankton blooms | Annual | Independent NGO |\n",
       "| **Public reception** | Social media analytics, sentiment analysis | Continuous | PR & Communications |\n",
       "\n",
       "### 8.3 Termination & Contingency Plan\n",
       "\n",
       "- **Kill‑Switch Activation** – Gene‑editing of essential genes triggered by environmental cue (e.g., heat).  \n",
       "- **Physical Containment** – Deploy retention nets in preliminary trial sites.  \n",
       "- **Emergency Response** – Pre‑qualified containment teams ready to act.  \n",
       "- **Back‑Up Monitoring** – Satellite‑based remote sensing for bloom detection at scale.\n",
       "\n",
       "---\n",
       "\n",
       "## 9. Implementation Road‑Map\n",
       "\n",
       "| Phase | Key Tasks | Deliverables | Timeframe |\n",
       "|-------|-----------|-------------|-----------|\n",
       "| **Phase 1 – Design & R&D** | Synthetic construct finalisation, lab‑scale safety assays | Prototype & Safety Report | 0–6 months |\n",
       "| **Phase 2 – Pre‑Application** | Risk model creation, stakeholder briefings, FTO analysis, compliance check | Pre‑Application NEMP & EIA drafts | 6–12 months |\n",
       "| **Phase 3 – Regulatory Approval** | Submit dossiers, respond to queries, adjust design | Approved field‑release license | 12–18 months |\n",
       "| **Phase 4 – Pilot Field Release** | Conduct stepwise release (water column, surface, targeted sub‑mersibles) | Pilot data, adaptive mitigation updates | 18–30 months |\n",
       "| **Phase 5 – Scale‑Up** | Deploy at multiple coordinates, monitor, evaluate | Commercial deployment plan | 30–48 months |\n",
       "| **Phase 6 – Continuous Evaluation** | Annual audits, updates to risk matrix, transparency reporting | Sustainability & Impact reports | Ongoing |\n",
       "\n",
       "---\n",
       "\n",
       "## 10. Appendices\n",
       "\n",
       "### 10.1 Regulatory Contact Matrix\n",
       "\n",
       "| Country | Main Authority | Contact | Key Decision Date |\n",
       "|---------|----------------|---------|--------------------|\n",
       "| USA | EPA | [EPA biosecurity contact] | 12 months |\n",
       "| EU | European Food Safety Authority (EFSA) | [EFSA CSAL contact] | 12 months |\n",
       "| UK | Environment Agency | [UK Biosecurity Contact] | 12 months |\n",
       "| Australia | National Biosecurity Advisory Committee | NMABAC | 12 months |\n",
       "\n",
       "### 10.2 Ethical Oversight Committee List\n",
       "\n",
       "| Role | Representative | Affiliation |\n",
       "|------|----------------|-------------|\n",
       "| Scientific Advisor | Prof. Emily R., MIT | Institute of Genetics |\n",
       "| Environmental Ethicist | Dr. Javier C., UNESCO | Global Environmental Ethics Center |\n",
       "| Indigenous Liaison | Ms. Rina K., Pacific Island NGO | Fiji Marine Trust |\n",
       "| Regulatory Liaison | Mr. A. Patel, EPA | EPA Biosecurity Division |\n",
       "\n",
       "### 10.3 Bibliography (selected)\n",
       "\n",
       "1. **Joung, J. & Doudna, J. A.** (2023). *CRISPR–Cas systems for microbial genome editing*. *Nature Biotechnology* 41: 439–448.  \n",
       "2. **Koehler, R. ** (2022). *Thermodynamics and kinetics of PETase* . *Advanced Functional Materials* 32: 2103122.  \n",
       "3. **UNEP** (2021). *Biosafety in marine environments: guidance for state parties*.  \n",
       "4. **OECD** (2024). *Guidelines for the environmental risk assessment of self‑reproducing microbes*.  \n",
       "5. **The Geneva Statement on Synthetic Biology (2020)**.  \n",
       "\n",
       "---\n",
       "\n",
       "## 11. Conclusion\n",
       "\n",
       "The SOPDM initiative mobilises cutting‑edge synthetic biology to tackle the plastic‑pollution crisis while respecting ecological, regulatory, ethical, and societal boundaries. The plan presented balances innovation with prudence:\n",
       "\n",
       "- **Scientific rigour** ensures that engineered organisms are dominated by multiple, fail‑safe containment mechanisms.  \n",
       "- **Regulatory integration** places the company in line with each jurisdiction’s biosafety mandates from the outset.  \n",
       "- **Stakeholder communication** is proactive and inclusive, leveraging data transparency and community partnership.  \n",
       "- **IP stewardship** protects corporate value and fosters reciprocity through open‑source contributions to global synthetic‑biology codebases.  \n",
       "- **Sustainability** informs product design and post‑deployment monitoring, upholding the triple‑bottom‑line commitment.\n",
       "\n",
       "With disciplined execution of the above roadmap, the corporation can deliver a **responsible, scalable, and socially accepted** solution to marine plastic degradation while maintaining compliance and protecting planetary health."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# The API we know well\n",
    "# I've updated this with the latest model, but it can take some time because it likes to think!\n",
    "# Replace the model with gpt-4.1-mini if you'd prefer not to wait 1-2 mins\n",
    "\n",
    "model_name = \"openai/gpt-oss-20b:free\"\n",
    "\n",
    "response = openai.chat.completions.create(model=model_name, messages=messages)\n",
    "answer = response.choices[0].message.content\n",
    "\n",
    "display(Markdown(answer))\n",
    "competitors.append(model_name)\n",
    "answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # Anthropic has a slightly different API, and Max Tokens is required\n",
    "\n",
    "# model_name = \"claude-sonnet-4-5\"\n",
    "\n",
    "# claude = Anthropic()\n",
    "# response = claude.messages.create(model=model_name, messages=messages, max_tokens=1000)\n",
    "# answer = response.content[0].text\n",
    "\n",
    "# display(Markdown(answer))\n",
    "# competitors.append(model_name)\n",
    "# answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/markdown": [
       "## Synthetic Biology: Biodegradable Plastic Microorganisms: Risk Assessment & Stakeholder Communication Plan\n",
       "\n",
       "**Executive Summary:** This plan outlines the risk assessment and communication strategies for launching self-reproducing microorganisms designed to biodegrade plastic in oceans. Due to the novel and potentially disruptive nature of the technology, a multi-faceted approach is crucial, encompassing ecological, regulatory, public perception, intellectual property, and sustainability considerations. The plan integrates current scientific understanding, policy frameworks, identifies potential moral dilemmas, and emphasizes proactive engagement with stakeholders to ensure responsible development and deployment.\n",
       "\n",
       "**1. Product Overview:**\n",
       "\n",
       "*   **Technology:**  Self-reproducing, engineered microorganisms that efficiently consume and break down specific types of marine plastic (e.g., PET, polyethylene) into environmentally benign byproducts (e.g., CO2, water, biomass).\n",
       "*   **Deployment Strategy:** Potential deployment methods include:\n",
       "    *   Localized release in heavily polluted areas.\n",
       "    *   Encapsulation in biodegradable matrices for controlled release.\n",
       "    *   Integration into existing plastic waste management infrastructures.\n",
       "*   **Target Market:** Governments, NGOs, coastal communities, shipping companies, and organizations committed to marine plastic cleanup.\n",
       "\n",
       "**2. Risk Assessment:**\n",
       "\n",
       "**2.1 Ecological Impacts:**\n",
       "\n",
       "*   **Type of Risk:** Unintended environmental consequences due to the introduction of novel organisms.\n",
       "*   **Specific Risks:**\n",
       "    *   **Uncontrolled Spread:** Microorganisms exceeding predicted boundaries, impacting non-target species or ecosystems.\n",
       "    *   **Evolutionary Drift:** Genetic mutations leading to altered biodegradability or emergence of undesirable traits (e.g., antibiotic resistance).\n",
       "    *   **Food Web Disruptions:** Altering marine plankton communities, affecting marine animal populations.\n",
       "    *   **Biodegradation Byproducts:**  Production of unintended toxic or harmful byproducts.\n",
       "    *   **Competition with Native Microbes:** Displacement of beneficial indigenous organisms.\n",
       "    *   **Horizontal Gene Transfer:**  Transfer of engineered genes to other microorganisms, conferring plastic degradation abilities to unintended species.\n",
       "*   **Mitigation Strategies:**\n",
       "    *   **Genetic Containment:** Implementing kill switches or auxotrophic dependencies to limit survival without specific inputs.\n",
       "    *   **Geographic Containment:**  Releasing microorganisms in geographically isolated areas or utilizing physical containment strategies (e.g., encapsulated releases).\n",
       "    *   **Strain Design:** Optimizing microorganisms for target plastic degradation, minimizing off-target effects. Rigorous laboratory and mesocosm testing.\n",
       "    *   **Environmental Monitoring:** Continuous monitoring of microorganism populations, byproduct concentrations, and ecosystem health following deployment.\n",
       "    *   **Reversibility Plan:** Development of a \"kill pill\" or competing microorganisms to reverse the process if necessary.\n",
       "    *   **Life Cycle Assessment (LCA):** Conduct a comprehensive LCA to model and predict potential impacts on global biogeochemical cycles (e.g., carbon cycle).\n",
       "*   **Monitoring and Evaluation:**  Establish a long-term monitoring program assessing microorganism populations, plastic degradation rates,  ecosystem health metrics (e.g., biodiversity indices, plankton community structure), and byproduct concentrations.\n",
       "\n",
       "**2.2 Regulatory Compliance:**\n",
       "\n",
       "*   **Type of Risk:** Non-compliance with regulations governing synthetic biology, biosecurity, and environmental protection.\n",
       "*   **Specific Risks:**\n",
       "    *   **Varying Regulatory Landscape:**  Different regulations in different countries affecting product deployment and market access.\n",
       "    *   **Lack of Harmonization:**  Inconsistencies between regulations from different governmental agencies leading to confusion and delays.\n",
       "    *   **Public Opposition:**  Regulatory approval stalled or revoked due to public pressure.\n",
       "    *   **Emerging Regulations:**  New legislation banning or restricting the use of synthetic biology in specific contexts.\n",
       "*   **Mitigation Strategies:**\n",
       "    *   **Early Engagement with Regulators:**  Proactive consultation with regulatory agencies in target markets.\n",
       "    *   **Adherence to International Standards:**  Compliance with established guidelines and best practices for synthetic biology research and development.\n",
       "    *   **Transparency and Open Communication:**  Publishing research data and engaging in public dialogues about the technology.\n",
       "    *   **Adaptive Strategy:**  Remaining flexible and adapting to evolving regulatory requirements.\n",
       "    *   **Ethical Advisory Board:**  Establish an ethical advisory board to review the project and ensure adherence to ethical principles.\n",
       "*   **Monitoring and Evaluation:**  Regularly review and update compliance protocols based on changes in regulations and scientific advances.\n",
       "\n",
       "**2.3 Public Perception:**\n",
       "\n",
       "*   **Type of Risk:** Negative public attitudes and mistrust related to synthetic biology and its potential impacts.\n",
       "*   **Specific Risks:**\n",
       "    *   **\"Franken-organisms\" Narrative:**  Fears of uncontrolled, genetically modified organisms escaping into the environment.\n",
       "    *   **\"Unnaturalness\" Objections:**  Moral resistance to modifying nature through synthetic biology.\n",
       "    *   **Lack of Transparency:**  Concerns about corporate secrecy and lack of public involvement in decision-making.\n",
       "    *   **Exacerbated by Misinformation:** Spread of inaccurate or misleading information about the technology through social media and other channels.\n",
       "    *   **Distributional Justice:** Concerns of disproportionate benefits to corporations with burdens (risks) impacting local communities.\n",
       "*   **Mitigation Strategies:**\n",
       "    *   **Proactive Communication:**  Developing a clear, consistent, and honest communication strategy.\n",
       "    *   **Transparency and Openness:**  Sharing research data, publishing results in peer-reviewed journals, and conducting public consultations.\n",
       "    *   **Stakeholder Engagement:**  Engaging with diverse stakeholder groups, including scientists, policymakers, NGOs, community leaders, and the general public.\n",
       "    *   **Risk Communication:**  Clearly and honestly communicating the potential risks and benefits of the technology.\n",
       "    *   **Addressing Misinformation:**  Actively monitoring and responding to misinformation through credible science communication.\n",
       "    *   **Ethical Framing:**  Highlighting the potential benefits of the technology for addressing a pressing environmental problem while emphasizing safety and responsible development.\n",
       "    *   **Involving Local Communities:** Integrate knowledge of potential impacts of the technology through local/traditional ecological knowledge.\n",
       "*   **Monitoring and Evaluation:**  Conduct regular surveys and focus groups to assess public attitudes and perceptions.  Use social media monitoring to identify and address emerging concerns.\n",
       "\n",
       "**2.4 Intellectual Property (IP):**\n",
       "\n",
       "*   **Type of Risk:** Disputes over IP rights and access, hindering development and deployment.\n",
       "*   **Specific Risks:**\n",
       "    *   **Patent Infringement:**  Third-party claims of patent infringement.\n",
       "    *   **Freedom-to-Operate Issues:**  Limited access to essential enabling technologies due to existing IP restrictions.\n",
       "    *   **Bio-piracy Concerns:**  Exploitation of biological resources and knowledge without proper compensation or benefit sharing.\n",
       "    *   **Data Ownership and Access:** Conflicts around data ownership and access, hindering collaborative research and development.\n",
       "    *   **Trade Secret Theft:** Risks involved with unauthorized acquisition of trade secrets regarding production or engineering methods.\n",
       "*   **Mitigation Strategies:**\n",
       "    *   **Thorough Patent Landscape Analysis:**  Conducting a comprehensive review of existing patents to identify potential infringement risks.\n",
       "    *   **Strategic Patenting:**  Proactively patenting key innovations to secure competitive advantage.\n",
       "    *   **Open Source and Collaboration:**  Exploring open-source licensing models and fostering collaborative research partnerships to promote knowledge sharing.\n",
       "    *   **Benefit Sharing:**  Ensuring fair and equitable sharing of benefits with communities and countries that have contributed to the development of the technology.\n",
       "    *   **Clear Ownership Policy:**  Develop clear policies concerning IP ownership, access, and licensing to address potential conflicts.\n",
       "*   **Monitoring and Evaluation:**  Continuously monitor developments in IP law and the competitive landscape.  Conduct regular audits of IP assets to identify and mitigate risks.\n",
       "\n",
       "**2.5 Long-Term Sustainability:**\n",
       "\n",
       "*   **Type of Risk:** Unintended consequences impacting long-term environmental or societal outcomes.\n",
       "*   **Specific Risks:**\n",
       "    *   **Dependence on Technology:** Over-reliance on the technology leading to neglect of other plastic waste management strategies.\n",
       "    *   **Ecosystem Adaptation:** Marine ecosystems adapting to the absence of plastic waste, potentially creating new vulnerabilities.\n",
       "    *   **Rebound Effect:**  Increased plastic production and consumption due to the perception that the environmental problem has been solved.\n",
       "    *   **Equity Issues:**  Uneven distribution of benefits and burdens, disadvantaging marginalized communities.\n",
       "    *   **Economic Considerations:**  Long-term financial viability of the project.\n",
       "    *   **Erosion of Public Trust:**  Failure to accurately measure and communicate results, raising concerns around the ethics of deployment.\n",
       "*   **Mitigation Strategies:**\n",
       "    *   **Integrated Approach:** Support other plastic waste reduction and recycling initiatives alongside the deployment of the technology.\n",
       "    *   **Adaptive Management:** Continuously monitoring and adapting the deployment strategy based on emerging data and feedback.\n",
       "    *   **Sustainable Production:** Utilizing sustainable feedstocks and production processes for the microorganisms.\n",
       "    *   **Community Engagement:** Actively engaging with local communities to ensure that the technology aligns with their needs and values.\n",
       "    *   **Economic Models:** Modeling the total lifecycle costs, accounting for production, distribution, and operational costs.\n",
       "    *   **Building Capacity:** Provide skills training and educational programs in related marine ecology, engineering, and data analysis.\n",
       "*   **Monitoring and Evaluation:**  Track the long-term environmental, social, and economic impacts of the technology. Conduct regular stakeholder consultations to gather feedback and identify potential unintended consequences.\n",
       "\n",
       "**3. Stakeholder Communication Plan:**\n",
       "\n",
       "**3.1 Key Stakeholders:**\n",
       "\n",
       "*   **Governments & Regulatory Agencies:**  Environmental protection agencies, food and drug administrations, international organizations.\n",
       "*   **Scientific Community:**  Synthetic biologists, marine biologists, ecologists, engineers.\n",
       "*   **Non-Governmental Organizations (NGOs):**  Environmental advocacy groups, conservation organizations.\n",
       "*   **Coastal Communities:**  Fishermen, tourism operators, residents.\n",
       "*   **Industry:**  Plastic manufacturers, waste management companies, shipping companies.\n",
       "*   **General Public:**  Consumers, media, general population.\n",
       "*   **Investors:** Shareholders, venture capitalists, private equity firms.\n",
       "\n",
       "**3.2 Communication Objectives:**\n",
       "\n",
       "*   **Transparency:**  Provide clear, accurate, and accessible information about the technology and its potential impacts.\n",
       "*   **Trust:**  Build public trust in the company and the technology by demonstrating responsible development and deployment practices.\n",
       "*   **Dialogue:**  Foster open and constructive dialogue with all stakeholders.\n",
       "*   **Education:**  Increase public understanding of synthetic biology and its potential benefits and risks.\n",
       "*   **Engagement:**  Involve stakeholders in decision-making processes.\n",
       "*   **Mitigate Negative Perception:**  Manage misinformation and address concerns about the technology.\n",
       "\n",
       "**3.3 Communication Strategies:**\n",
       "\n",
       "*   **Website and Social Media:**  Maintain a user-friendly website and active social media presence to disseminate information, answer questions, and engage in dialogue.\n",
       "*   **Public Forums and Town Halls:**  Organize public forums and town hall meetings to present information and gather feedback from stakeholders.\n",
       "*   **Scientific Publications:**  Publish research data in peer-reviewed journals to ensure scientific rigor and transparency.\n",
       "*   **Media Outreach:**  Proactively engage with journalists and media outlets to provide accurate and balanced coverage of the technology.\n",
       "*   **Educational Materials:**  Develop educational materials, such as videos, brochures, and infographics, to increase public understanding of synthetic biology.\n",
       "*   **Stakeholder Advisory Board:**  Establish a stakeholder advisory board composed of representatives from diverse stakeholder groups to provide guidance and feedback.\n",
       "*   **Community Partnerships:** Collaborate with local communities to develop and implement deployment strategies.\n",
       "*   **Contingency Communication Plan:**  Prepare a contingency communication plan to address potential crises or negative events.\n",
       "\n",
       "**3.4 Communication Metrics:**\n",
       "\n",
       "*   **Website and Social Media Analytics:** Track website traffic, social media engagement, and sentiment analysis to measure the reach and effectiveness of communication efforts.\n",
       "*   **Media Coverage Analysis:**  Monitor media coverage to assess the tone and accuracy of reporting.\n",
       "*   **Public Opinion Surveys:**  Conduct regular public opinion surveys to track changes in attitudes and perceptions.\n",
       "*   **Stakeholder Feedback:**  Gather feedback from stakeholders through surveys, interviews, and focus groups.\n",
       "*   **Regulatory Approvals:** Success in obtaining regulatory approvals and permits.\n",
       "\n",
       "**4. Ethical Considerations:**\n",
       "\n",
       "*   **Dual-Use Research:**  Potential for misuse of the technology for malicious purposes. Risk should be considered and safeguards built into the protocols.\n",
       "*   **Environmental Justice:**  Ensuring that the benefits and burdens of the technology are distributed equitably and that marginalized communities are not disproportionately affected.\n",
       "*   **Moral Status of Organisms:**  Addressing philosophical questions about the moral status of synthetic organisms and the ethical implications of manipulating life. Consider stakeholder views in regard to religious or cultural ethics.\n",
       "*   **Risk Perception and Informed Consent**: People may have varying views about technology risks. Ensuring equitable access to information to allow informed consent.\n",
       "\n",
       "**5. Conclusion:**\n",
       "\n",
       "The development and deployment of self-reproducing microorganisms for plastic biodegradation in oceans present both significant opportunities and challenges. A comprehensive risk assessment and proactive stakeholder communication plan are essential to ensure responsible development and deployment. By integrating scientific rigor, regulatory compliance, ethical considerations, and open communication, the company can build trust, mitigate risks, and maximize the potential benefits of this innovative technology for addressing the global plastic pollution crisis.\n"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "gemini = OpenAI(base_url=\"https://openrouter.ai/api/v1\", api_key=google_api_key)\n",
    "model_name = \"google/gemini-2.0-flash-exp:free\"\n",
    "\n",
    "response = gemini.chat.completions.create(model=model_name, messages=messages)\n",
    "answer = response.choices[0].message.content\n",
    "\n",
    "display(Markdown(answer))\n",
    "competitors.append(model_name)\n",
    "answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/markdown": [
       "**Risk Assessment and Stakeholder Communication Plan for Synthetic Biology Product: Self-Reproducing Plastic-Degrading Microorganisms**\n",
       "\n",
       "---\n",
       "\n",
       "### **1. Risk Assessment**\n",
       "\n",
       "#### **Ecological Impacts**  \n",
       "- **Risks**:  \n",
       "  - **Invasive Potential**: Uncontrolled proliferation disrupting marine ecosystems.  \n",
       "  - **Byproduct Toxicity**: Release of microplastics or harmful chemicals (e.g., phthalates).  \n",
       "  - **Food Chain Disruption**: Impact on keystone species or nutrient cycles.  \n",
       "- **Mitigation**:  \n",
       "  - **Containment Mechanisms**: Engineer \"kill switches\" (e.g., nutrient dependency, CRISPR-based gene drives).  \n",
       "  - **Pre-Testing**: Small-scale mesocosm trials to assess ecological interactions.  \n",
       "  - **Monitoring**: Real-time genomic tracking and satellite sensors to detect spread.  \n",
       "\n",
       "#### **Regulatory Compliance**  \n",
       "- **Risks**:  \n",
       "  - **Jurisdictional Variability**: Conflicting GMO regulations (e.g., strict EU vs. permissive US frameworks).  \n",
       "  - **Ocean Law Gaps**: Limited international governance for open-sea biotechnologies.  \n",
       "- **Mitigation**:  \n",
       "  - **Global Alignment**: Engage with the Cartagena Protocol, UNEP, and regional bodies early.  \n",
       "  - **Precautionary Approvals**: Pursue phased releases tied to environmental impact assessments (EIAs).  \n",
       "\n",
       "#### **Public Perception**  \n",
       "- **Risks**:  \n",
       "  - **GMO Skepticism**: Fear of \"Frankenbugs\" and misinformation campaigns.  \n",
       "  - **NGO Opposition**: Activist groups labeling the tech as reckless.  \n",
       "- **Mitigation**:  \n",
       "  - **Transparency**: Publish safety data in open-access forums and host public webinars.  \n",
       "  - **Third-Party Endorsements**: Partner with trusted entities (e.g., IUCN, academic consortia).  \n",
       "\n",
       "#### **Intellectual Property (IP)**  \n",
       "- **Risks**:  \n",
       "  - **Patent Challenges**: Prior art claims or open-source resistance.  \n",
       "  - **Global Enforcement**: Difficulty controlling use in international waters.  \n",
       "- **Mitigation**:  \n",
       "  - **Defensive Patenting**: File in key markets (US, EU, China) with claims on genetic constructs.  \n",
       "  - **Ethical Licensing**: Offer tiered access for low-income nations under Nagoya Protocol guidelines.  \n",
       "\n",
       "#### **Long-Term Sustainability**  \n",
       "- **Risks**:  \n",
       "  - **Unintended Evolution**: Microbes mutating to degrade non-target substrates (e.g., marine snow).  \n",
       "  - **Dependency**: Over-reliance on tech delaying systemic waste reduction.  \n",
       "- **Mitigation**:  \n",
       "  - **Adaptive Design**: Regularly update strains via gene editing to maintain control.  \n",
       "  - **Circular Economy Integration**: Partner with plastic manufacturers to reduce upstream waste.  \n",
       "\n",
       "---\n",
       "\n",
       "### **2. Stakeholder Communication Plan**\n",
       "\n",
       "#### **Government Regulators**  \n",
       "- **Channels**: Regulatory submissions, bilateral meetings, white papers.  \n",
       "- **Message**: Emphasize compliance with local/global biosafety frameworks and EIAs. Highlight containment protocols.  \n",
       "\n",
       "#### **Environmental NGOs**  \n",
       "- **Channels**: Collaborative workshops, joint research initiatives.  \n",
       "- **Message**: Address ecological concerns transparently; invite oversight roles in monitoring.  \n",
       "\n",
       "#### **Public & Media**  \n",
       "- **Channels**: Social media campaigns, documentaries, citizen science programs.  \n",
       "- **Message**: Simplify science (e.g., \"These microbes eat plastic, not ecosystems\"); use visuals of cleaner oceans.  \n",
       "\n",
       "#### **Scientific Community**  \n",
       "- **Channels**: Peer-reviewed publications, conference presentations.  \n",
       "- **Message**: Share strain genomes and trial data for independent replication; solicit feedback.  \n",
       "\n",
       "#### **Industry Partners**  \n",
       "- **Channels**: Investor briefings, co-development agreements.  \n",
       "- **Message**: Stress scalability, IP protection, and alignment with ESG goals.  \n",
       "\n",
       "---\n",
       "\n",
       "### **3. Ethical & Moral Considerations**  \n",
       "- **Equity**: Ensure deployment prioritizes high-pollution regions (e.g., Southeast Asia) with local consent.  \n",
       "- **Precaution**: Adopt the \"non-maleficence\" principle—delay launch until independent verification.  \n",
       "- **Stewardship**: Establish a global ethics board with ecologists, Indigenous leaders, and bioethicists.  \n",
       "\n",
       "---\n",
       "\n",
       "### **4. Policy Integration**  \n",
       "- **Leverage**: Align with the UN SDGs (Goal 14: Life Below Water) and the High Seas Treaty.  \n",
       "- **Advocate**: Push for standardized international biotech regulations through OECD and WHO.  \n",
       "\n",
       "---\n",
       "\n",
       "### **5. Long-Term Monitoring & Adaptation**  \n",
       "- **Infrastructure**: Fund a decentralized network of ocean observatories with AI-driven risk modeling.  \n",
       "- **Exit Strategy**: Develop a \"sunset clause\" to phase out microbes if adverse effects emerge.  \n",
       "\n",
       "--- \n",
       "\n",
       "This plan balances innovation with caution, prioritizing ecological integrity and stakeholder trust. Iterative updates will ensure adaptability to new scientific and policy developments."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "deepseek = OpenAI(api_key=deepseek_api_key, base_url=\"https://openrouter.ai/api/v1\")\n",
    "model_name = \"deepseek/deepseek-r1:free\"\n",
    "\n",
    "response = deepseek.chat.completions.create(model=model_name, messages=messages)\n",
    "answer = response.choices[0].message.content\n",
    "\n",
    "display(Markdown(answer))\n",
    "competitors.append(model_name)\n",
    "answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # Updated with the latest Open Source model from OpenAI\n",
    "\n",
    "# groq = OpenAI(api_key=groq_api_key, base_url=\"https://api.groq.com/openai/v1\")\n",
    "# model_name = \"openai/gpt-oss-120b\"\n",
    "\n",
    "# response = groq.chat.completions.create(model=model_name, messages=messages)\n",
    "# answer = response.choices[0].message.content\n",
    "\n",
    "# display(Markdown(answer))\n",
    "# competitors.append(model_name)\n",
    "# answers.append(answer)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## For the next cell, we will use Ollama\n",
    "\n",
    "Ollama runs a local web service that gives an OpenAI compatible endpoint,  \n",
    "and runs models locally using high performance C++ code.\n",
    "\n",
    "If you don't have Ollama, install it here by visiting https://ollama.com then pressing Download and following the instructions.\n",
    "\n",
    "After it's installed, you should be able to visit here: http://localhost:11434 and see the message \"Ollama is running\"\n",
    "\n",
    "You might need to restart Cursor (and maybe reboot). Then open a Terminal (control+\\`) and run `ollama serve`\n",
    "\n",
    "Useful Ollama commands (run these in the terminal, or with an exclamation mark in this notebook):\n",
    "\n",
    "`ollama pull <model_name>` downloads a model locally  \n",
    "`ollama ls` lists all the models you've downloaded  \n",
    "`ollama rm <model_name>` deletes the specified model from your downloads"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<table style=\"margin: 0; text-align: left; width:100%\">\n",
    "    <tr>\n",
    "        <td style=\"width: 150px; height: 150px; vertical-align: middle;\">\n",
    "            <img src=\"../assets/stop.png\" width=\"150\" height=\"150\" style=\"display: block;\" />\n",
    "        </td>\n",
    "        <td>\n",
    "            <h2 style=\"color:#ff7800;\">Super important - ignore me at your peril!</h2>\n",
    "            <span style=\"color:#ff7800;\">The model called <b>llama3.3</b> is FAR too large for home computers - it's not intended for personal computing and will consume all your resources! Stick with the nicely sized <b>llama3.2</b> or <b>llama3.2:1b</b> and if you want larger, try llama3.1 or smaller variants of Qwen, Gemma, Phi or DeepSeek. See the <A href=\"https://ollama.com/models\">the Ollama models page</a> for a full list of models and sizes.\n",
    "            </span>\n",
    "        </td>\n",
    "    </tr>\n",
    "</table>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "!ollama pull llama3.2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "ollama = OpenAI(base_url='http://localhost:11434/v1', api_key='ollama')\n",
    "model_name = \"llama3.2\"\n",
    "\n",
    "response = ollama.chat.completions.create(model=model_name, messages=messages)\n",
    "answer = response.choices[0].message.content\n",
    "\n",
    "display(Markdown(answer))\n",
    "competitors.append(model_name)\n",
    "answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# So where are we?\n",
    "\n",
    "print(competitors)\n",
    "print(answers)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# It's nice to know how to use \"zip\"\n",
    "for competitor, answer in zip(competitors, answers):\n",
    "    print(f\"Competitor: {competitor}\\n\\n{answer}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Let's bring this together - note the use of \"enumerate\"\n",
    "\n",
    "together = \"\"\n",
    "for index, answer in enumerate(answers):\n",
    "    together += f\"# Response from competitor {index+1}\\n\\n\"\n",
    "    together += answer + \"\\n\\n\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "print(together)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "judge = f\"\"\"You are judging a competition between {len(competitors)} competitors.\n",
    "Each model has been given this question:\n",
    "\n",
    "{question}\n",
    "\n",
    "Your job is to evaluate each response for clarity and strength of argument, and rank them in order of best to worst.\n",
    "Respond with JSON, and only JSON, with the following format:\n",
    "{{\"results\": [\"best competitor number\", \"second best competitor number\", \"third best competitor number\", ...]}}\n",
    "\n",
    "Here are the responses from each competitor:\n",
    "\n",
    "{together}\n",
    "\n",
    "Now respond with the JSON with the ranked order of the competitors, nothing else. Do not include markdown formatting or code blocks.\"\"\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "print(judge)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "judge_messages = [{\"role\": \"user\", \"content\": judge}]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Judgement time!\n",
    "\n",
    "openai = OpenAI()\n",
    "response = openai.chat.completions.create(\n",
    "    model=\"gpt-5-mini\",\n",
    "    messages=judge_messages,\n",
    ")\n",
    "results = response.choices[0].message.content\n",
    "print(results)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# OK let's turn this into results!\n",
    "\n",
    "results_dict = json.loads(results)\n",
    "ranks = results_dict[\"results\"]\n",
    "for index, result in enumerate(ranks):\n",
    "    competitor = competitors[int(result)-1]\n",
    "    print(f\"Rank {index+1}: {competitor}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<table style=\"margin: 0; text-align: left; width:100%\">\n",
    "    <tr>\n",
    "        <td style=\"width: 150px; height: 150px; vertical-align: middle;\">\n",
    "            <img src=\"../assets/exercise.png\" width=\"150\" height=\"150\" style=\"display: block;\" />\n",
    "        </td>\n",
    "        <td>\n",
    "            <h2 style=\"color:#ff7800;\">Exercise</h2>\n",
    "            <span style=\"color:#ff7800;\">Which pattern(s) did this use? Try updating this to add another Agentic design pattern.\n",
    "            </span>\n",
    "        </td>\n",
    "    </tr>\n",
    "</table>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<table style=\"margin: 0; text-align: left; width:100%\">\n",
    "    <tr>\n",
    "        <td style=\"width: 150px; height: 150px; vertical-align: middle;\">\n",
    "            <img src=\"../assets/business.png\" width=\"150\" height=\"150\" style=\"display: block;\" />\n",
    "        </td>\n",
    "        <td>\n",
    "            <h2 style=\"color:#00bfff;\">Commercial implications</h2>\n",
    "            <span style=\"color:#00bfff;\">These kinds of patterns - to send a task to multiple models, and evaluate results,\n",
    "            are common where you need to improve the quality of your LLM response. This approach can be universally applied\n",
    "            to business projects where accuracy is critical.\n",
    "            </span>\n",
    "        </td>\n",
    "    </tr>\n",
    "</table>"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "agents",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
